CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Alfasigma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Storage Stable Composition Comprising Rifaximin AlphaSANDOZSep 22, 2022
Pharmaceutical Composition Containing Rifaximin Alpha & DeltaSANDOZMar 21, 2022
Oral Dosage Form Comprising Rifaximin In Form BetaSANDOZAug 27, 2020
Storage Stable Composition Comprising Rifaximin AlphaSANDOZJan 24, 2020
Pharmaceutical Composition Containing Rifaximin Alpha&DeltaSANDOZJun 12, 2019

Explore Alfasigma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 20, 2023Pharmaceutical Compositions Comprising A Jak Inhibitor3
Jun 1, 2022Process For Mesalazine Solid Formulations1
Nov 1, 2017Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease1
Jun 7, 2017Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved2
Apr 19, 2017Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin3

Top competitors of Alfasigma

List of top competitors of Alfasigma based on patent oppositions.